Cancer and Listeria Bernard Liu. Need Cancer

Slides:

Advertisements

Similar presentations

Therapy-Related Cardiac Toxicity in Cancer Patients JEAN-BERNARD DURAND, M.D., FCCP, FACC ASSOCIATE PROFESSOR OF MEDICINE MEDICAL DIRECTOR CARDIOMYOPATHY.

Advertisements

Hairy Cell Leukemia Foundation and

Option D1 Pharmaceutical Products.  Generally a drug or medicine is any chemical (natural or man made), which does one or more of the following:  Alters.

EU RTD + FP Cancer Treatment: A priority for patients in Europe 7 th European Health Forum Bad Gastein 7 October, 2004 Cornelius Schmaltz MD European.

Hybrid Tumor Vaccines David L. Liu, MD, PhD Professor of Surgery and Oncology Tumor Immunotherapy Division RedSun Institute 242 Dorchester Street, Boston,

State of the Region Overview of APR Data for the Western Region Western Regional Resource Center APR Clinic 2010 November 1-3, 2010 San Francisco, California.

1 Institute of Epidemiology and Infectious Diseases Research Activities The L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases Svetlana.

Brain tumors = leading cause of solid tumor deaths in children Low grade brain tumors = most common NO CURES CURRENT TREATMENT = TOXIC Better treatments.

Prostate Needle Biopsy: The Pitfalls and the Role of the Pathologist – Patient Track Prostate Cancer Symposium “Intriguing Cases / Emerging Strategies.

Clinical & Translational Science: Individualizing Cancer Immunotherapy Scott A. Waldman, MD, PhD, FCP Thomas Jefferson University.

Introducing Apceden™.

AJCC TNM Staging 7th Edition Melanoma Case #2

Malignant Melanoma and CDKN2A

Driving the Transition to Individualized Cancer Treatment by Addressing Critical Questions 1 Do I need surgery? chemotherapy? radiation? INVASIVE BREAST.

Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal. Eng C1, Rogers J2, Chang GJ3, You N3, Das P4, Rodriguez-Bigas.

Oncolytic Viruses “Onco” = cancer “Lytic” = killing An innovative cancer therapy that seeks to harness the natural properties of viruses to aid in the.

Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2.

Bernard A Fox, PhD Immediate Past President and Chair, Executive Council Society for Immunotherapy of Cancer (SITC) Defining the Critical Hurdles in Cancer.

Unknown Primary Tumors: Newer Concepts and Approches “ 10 years experience of a Comprehensive Cancer Center” Valerio Ramazzotti S.C. Epidemiologia Roma.

1 COMBIDEX ® (ferumoxtran-10). Introduction, Combidex, Indication Mark Roessel Vice President Regulatory Affairs, Advanced Magnetics, Inc.

Timeliness of Cancer Registry Reporting Ali Johnson, CTR Vermont Cancer Registry Vermont Explor Annual Data Meeting May 1, 2006.

Translational Science in Cancer Health Disparities Research Peter Ujhazy, M.D., Ph.D. Program Director Translational Research Program Division of Cancer.

MEDICAL LABORATORY TECHNOLOGY What will I do? Perform tests on human blood, tissue and fluid Be a part of the health care team Help the doctor diagnose.

Immunotherapy Sara Engh & Tenzin Yiga. Role of the Immune system ➔ Defends against pathogens such as bacteria, fungi, and viruses that enter the body.

A Model for Translating Research into Practice in the United States - Mexico Border Region Howard J. Eng, MS, DrPH Director, Southwest Border Rural Health.

Phase I Study of PLX4032: Proof of Concept for V600E BRAF Mutation as a Therapeutic Target in Human Cancer Flaherty K et al. American Society of Clinical.

Measuring Technical Progress and Potential Impact in Real Time Presented at the American Evaluation Association Conference 2009 by Jerald Hage, Wilbur.

Elizabeth Gorevski Kingsbrook Jewish Medical Center Brooklyn, NY.

Laboratory Careers Packet #4. Introduction Individuals working in this field have various tasks, duties, interests and abilities. Laboratory personnel.

Patched is a 12 pass transmembrane receptor: Patched is the receptor for the key signaling protein Hedgehog.

1 News from American Society of Clinical Oncology Meeting June 2011 (Lung and Skin) Paul Donnellan Consultant Medical Oncologist Galway University Hospitals.

Analysis of tumor-initiating cells in engrafted patient-derived human bladder carcinomas may direct precise cancer therapy Onyi Balogun 1†, Jukes Namm.

Basic Immunology of the Mouse (and Human) Nicholas P. Restifo, MD October 19, 2015.

Immunotherapy (Cancer therapy with T-Cells)

FANCD2 & the Fanconi Anemia Tumor Suppressor Pathway Shayna Purcell Joo et al., 333 (6040):

Progress in Cancer Therapy Following Developments in Biopharma

Oral Health and Diabetes: A Two Way Street Maria Emanuel Ryan D.D.S., Ph.D. Professor of Oral Biology and Pathology Associate Dean of Strategic Planning.

Welcome to Asian Institute of Medical Sciences

By: Joanne Pugliese. Nanotechnology is the science and study of particles at a molecular or atomic level. Manipulation of molecules at the atomic level.

What should patients with BRAF mutant melanoma receive as front line therapy? Antoni Ribas, M.D. Professor of Medicine Professor of Surgery Professor of.

ABSTRACT Purpose This retrospective review was conducted to determine if delay in the start of radiotherapy after conservative breast surgery had any detrimental.

WHAT DO YOU KNOW ABOUT HIV?. Using Lethal Mutagenesis to Combat HIV Matt Armstrong G/T Independent Research Fighting Fire with Fire.

Wei Yuan, Lydia Medeiros, Janet Buffer, Patricia Kendall, John Sofos Registered dietitians and registered nurses lack awareness and knowledge of Listeria.

CASE PRESENTATION BREAST CANCER.

SD Walter MD1, T Mahten MD2, JW Harbour MD1,3

Zeyu Chen,Rong Guo,Jianghong Xu,Chuangjun Qiu

Broadening Eligibility Criteria to Make Clinical Trials More Representative Joint Recommendations of the American Society of Clinical Oncology and Friends.

Dose-escalation patient response.

Immunotherapeutics 18th Annual Research Retreat

Genomic Medicine Centre Overview

Genomic Medicine Centre Overview

Chemoprevention of nonmelanoma skin cancer

The Melanoma Epidemic Thus Far

Isaac M. Bromberg, MD Journal of Pain and Symptom Management

B. Smith, J. T. Larsson, M. Lisby, L. Müller, S. B. Madsen, J

Volume 154, Issue 1, Pages (January 2018)

Modeling the cancer patient with genetically engineered mice

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Genomic Medicine Centre Overview

Immune-Modulating Vaccines in Non-small Cell Lung Cancer

Target disease and target populations for 21st century vaccine developmentIncluded in the list are the agents of infectious diseases for which vaccines.

PLAYMATES LEARNING CENTER CALENDAR

Table 1. Diagnostic methods for systemic fungal infection (n=70)

Malignancy-related events over time for all-bari-RA analysis set (IR).

Receipt of Adjuvant Endometrial Cancer Treatment According to Race NRG Oncology/Gynecologic Oncology Group (GOG) 210 Study Ashley Felix, PhD, MPH Assistant.

Table 2. Demographic characteristics of the study subjects

Clinical outcomes resulting from inhibition of tumor-intrinsic and myeloid NF-κB activation in melanoma chemotherapy. Clinical outcomes resulting from.

Influenza vaccine enhances NK cell function through IFN-α.

Control chart demonstrating percent of patients up to date on PPSV23 out of total number of eligible clinic patients. Control chart demonstrating percent.

Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.

Presentation transcript:

Cancer and Listeria Bernard Liu

Need

Cancer

Non-melanoma Skin Cancer

Melanoma Skin Cancer

Causes

Prognosis

Listeria monocytogenes

Lovaxin C

Bibliography Biello, David. “Irradiated Pathogens Used to Create Potent Vaccine.” Scientific American. 26 June, Brockstedt, Dirk et. al. “Listeria-based cancer vaccines that segregate immunogenicity from toxicity.” Proceedings of the National Academy of Sciences. 21 Sept, Greenameier, Larry. “Recruiting a Dangerous Foe to Fight Cancer and HIV” Scientific American. 21 May, Hantel, Alexander et. al. “Listeriosis in the Setting of Malignant Disease.” The Johns Hopkins Oncology Center and the Department of Laboratory Medicine (Pathology). 14 Dec, Journal of the National Cancer Institute. "Perfluorinated Chemicals Not Associated With Cancer In General Population, Study Suggests." ScienceDaily 9 April Pan, Zhen-Kun et. al. “Regression of Established B16F10 Melanoma with a Recombinant Listeria monocytogenes Vaccine.” Journal of Cancer Research. 1 November Pan, Zhen-Kun et. al. “Regression of Established Tumors in Mice Mediated by the Oral Administration of a Recombinant Listeria monocytogenes Vaccine.” Journal of Cancer Research. 15 October Safdar, Amar and Donald Armstrong. “Antimicrobial Activities against 84 Listeria monocytogenes Isolates from Patients with Systemic Listeriosis at a Comprehensive Cancer Center ( ).” Journal of Clinical Microbiology. Jan, Stix, Gary. “Special Delivery.” Scientific American. 20 May, Swaminathan, Nikhil. “Chemotherapy Thwarted by Cancer-Killing Gene.” Scientific American. 15 May, “The First Use Of A Live Listeria Cancer Vaccine In Humans” Medical News Today. 16 Apr, University Of California, Berkeley. “Cancer Vaccine Based On Pathogenic Listeria Bacteria Shows Promise Targeting Metastases.” ScienceDaily. 30 September, Wapner, Jessica. “Cancer Vaccine: Looking Beyond Tumor Size.” Scientific American. 4 November, 2008.